IMPAX CV Pediatric Echo Reporting, IMPAX CV Echo Measurement Import via Optical Character Recognition (OCR) Service IMPAX. For the creation of digital structured reports for cardiovascular diagnostic studies such as echocardiography.
Published June 4, 2014 · Recall initiated: April 30, 2014
Summary
FDA records medical device Class II recall Z-1662-2014, published June 4, 2014 and initiated April 30, 2014. Recalling firm: AGFA Corp.; Status: Terminated; Reported quantity: One; Lot: Model L9M21000 - Software versions: IMPAX CV 7.8 SU3/SU4 - OCR Service. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failure to effectively install and test a hotfix to correct the known software defect within the IMPAX CV 7.8 SU3-OCR Service.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AGFA Corp.
- Distributor
- Distribution to SC only
- Lot
- Model L9M21000 - Software versions: IMPAX CV 7.8 SU3/SU4 - OCR Service
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAGFA Digital Radiography X-Ray system DX-D 100 Agfa's DX-D 100 is indicated for use in providing diagnosticJuly 30, 2014
- FDAMedtronic Temporary Pacemaker, Model 5348. Single Chamber External Pulse Generator (EPG) Temporary PacemakerJune 4, 2014
- FDAMAGNETOM Aera magnetic resonance system. Indicated for use as a magnetic resonance diagnostic device (MRDD)June 4, 2014
- FDAIMPAX RIS QDOC 5.8February 12, 2014
- FDAIMPAX 5.2 DB Server (running Oracle 10.1.0.4.0), medical imaging Picture Archiving and Communication SystemOctober 30, 2013
- FDAAGFA Digital Radiography X-Ray System DX-D 100 Agfa's DX-D 100 is indicated for use in providing diagnosticJune 12, 2013
Questions about this recall
Was IMPAX CV Pediatric Echo Reporting, IMPAX CV Echo Measurement Import via Optical Character Recognition (OCR) Service IMPAX. For the creation of digital structured reports for cardiovascular diagnostic studies such as echocardiography. recalled?
Yes. FDA published recall Z-1662-2014 on June 4, 2014. Reported hazard: Failure to effectively install and test a hotfix to correct the known software defect within the IMPAX CV 7.8 SU3-OCR Service.
What should I do if I have this product?
Voluntary: Firm initiated · Letter